Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines

Veitch, Andrew; Vanbiervliet, Geoffroy; Gershlick, Anthony; Boustière, Christian; Baglin, Trevor; Smith, Lesley‐Ann; Radaelli, Franco; Knight, Evelyn; M. Gralnek, Ian; Hassan, Cesare; Dumonceau, Jean‐Marc

doi:10.1136/gutjnl-2015-311110

Public

Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines

Published in Gut • Feb 12, 2016

Authors:

Andrew Veitch

Geoffroy Vanbiervliet

Anthony Gershlick

Abstract

The risk of endoscopy in patients on antithrombotics depends on the risks of procedural haemorrhage versus thrombosis due to discontinuation of therapy. P2Y12 RECEPTOR ANTAGONISTS CLOPIDOGREL, PRASUGREL, TICAGRELOR: For low-risk endoscopic procedures we recommend continuing P2Y12 receptor antagonist...

Subject

Medicine

Endoscopy

Gastroenterology

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!